Navigation Links
Phylonix granted broad European patent for transplanting human cells into zebrafish
Date:12/18/2007

Cambridge, MA -- December 18, 2007 -- Phylonix Pharmaceuticals today announced that it recently received a broadly issued European patent EP 1 135 531 B1: Methods for Introducing Heterologous Cells into Fish. The patent, which has issued in key European countries, encompasses 68 claims, including transplanting stem cells, cancer cells and pathogens. In addition, neurons, chondrocytes, renal and hepatic cells can be transplanted in zebrafish and effects of growth factors or cytotoxic agents can be assessed. Claims also cover recovering cells for potential tissue engineering or transplantation applications. Many of these claims have issued previously in the United States and other countries.

This award complements our previously issued patents for assessing angiogenesis, apoptosis and toxicity in zebrafish, and use of high-throughput screening methods such as microplate analysis, commented Patricia McGrath, Phylonix President and Chief Executive Officer.

Cells that proliferate in their native environment also proliferate when transplanted into zebrafish; cells that are incapable of proliferating in their native environment usually do not proliferate in zebrafish.

Advantages of Zebrafish for Transplantation

Currently, the mouse is the model system of choice for cell transplantation assays. However, to prevent cell rejection, transplantation of human cells must be performed using immunosuppressed mice and these animals are expensive to develop and maintain. In comparison, cell transplantation in zebrafish larvae is simple and cost effective, and immunosuppression is not necessary.

There are several additional advantages of using zebrafish for transplantation assays. All essential components of vertebrate form and organ development are mimicked in the transparent zebrafish and their molecular basis is either identical or similar, underscoring the potential for use in research on human diseases. Due to the small size of zeb
'/>"/>

Contact: Edward O'Lear
ed.olear@phylonix.com
617-441-6700
Phylonix Pharmaceuticals
Source:Eurekalert

Page: 1 2

Related medicine news :

1. NIH awards Phylonix phase II SBIR to develop zebrafish models for eye diseases
2. PREOS(R) Granted U.S. Orphan Drug Status for Treatment of Hypoparathyroidism
3. Abbott Broadens Use of i-STAT Handheld Blood Analyzer with CLIA Waiver Granted by FDA for CHEM8+ Test Cartridge
4. USC granted $8.4 million for autism research
5. Aida Granted Additional Anti-Cancer Patent
6. CME LLC Granted Five-Year Full Approval by the American Psychological Association
7. ActiPatch(TM) Granted Market Clearance by the Food & Drug Administration in the Kingdom of Jordan
8. TREANDA New Drug Application for the Treatment of Chronic Lymphocytic Leukemia Granted Priority Review Status by FDA
9. Neurochem announces eprodisate (KIACTA(TM)) receives acknowledgement of complete response and is granted Class 2 review
10. Isis Announces ISIS 333611 Granted Orphan Drug Status for Treatment of ALS
11. Broad-based group of physicians calls for improvement in stroke treatment

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...ov.25/PRNewswire-USNewswire/--Whenmostpeoplehearth...orcanalsogivepatientsthehelptheyneed.TMJstandsfort...dible)contacts/connectswithyourskull(temporalbone)...unctionarepainwithchewing,clickingorpoppingoftheja...nincluding:headaches,fatigue,sleepdisturbances,irr...
(Date:11/25/2009)...lif.,Nov.25/PRNewswire-FirstCall/-- OnyxPharmaceu...panywillhosttwoinvestoreventsinDecember: ,, A...00a.m.ET ,, Principalinvestigatorswilldiscuss...nd/orrefractorymultiplemyeloma,asfeaturedatthe51st...positioninNewOrleans,LA.Theteleconferencewillbegin...
(Date:11/25/2009)...5/PRNewswire/-SentinelleMedicalInc.,aleadingmanufa...warelaunchesasuiteofnewleadingedgeclinicalapplicat...thisyear,sRadiologicalSocietyofNorthAmerica(RSNA)a...HallA).Theapplicationsleveragetheuniquehighquality...coilsandsupportmultipleimagingmodalitiesformulti-p...
(Date:11/25/2009)...Md.,Nov.25/PRNewswire-USNewswire/--AnarticlebyJane...uationandResearch,titled"ADifficultBalance-PainMan...009issueofTheNewEnglandJournalofMedicine. ,, (L...FDALOGO ) ,, Inthearticle,WoodcockdiscussesFDAe...nforthosewhoneeditandmanagingtherisksposedbyvariou...
(Date:11/25/2009)...Nov.25/PRNewswire/--TheBayAreaAirQualityManagement... the Air Alert forThursday,November26,20...hersolidfuel,bothindoorsandoutdoors. ,, "Cold,s...rrow,"saidJackBroadbent,executiveofficeroftheAirDi...lthoftheirneighborsandfellowcommunitymembersthisTh...
Breaking Medicine News(10 mins):Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2
...e University of Michigan Health System say the fed...he elderly in a cost-effective manner that would u...eral government were to start a Flu vaccination pr...o are at a higher risk of death due to influenza v...
...sed by researchers at Medical College of Wisconsin... the improvement in survival rate in cardiac arres...study would be funded by the National Heart, Lung,...arrest and severe traumatic injury, and would be s...
...ical major Ranbaxy Laboratories Limited Friday ann...for asthma patients//. "Ranbaxy has introduce...e is available in HFA (Hydroxy fluoro Alkane: the ...de HFA Inhaler, as opposed to the conventional CFC...
...d Health Organization (WHO), two fresh cases of po...another from Mudug region//, in southern Somalia a...s, with security-related restrictions, present a r... a total of 199 children to date, but which appear...
...study conducted by Theodore Blaine, M.D., assistan...versity Medical Center and an attending// surgeon ...te, a drug that is FDA-approved for osteoarthritis...ox-2 inhibitors. After that people went for surger...
...r of drug resistance TB is becoming apparent to th...t time. The Union Ministry is now pulling up// its...resistant MDR-TB. DOTS Plus, or directly obs... Maharashtra and Gujarat. 100 MDR-TB cases are env...
Other Medicine News:Health News:Influenza Vaccination For The Elderly 2Health News:An Effective Drug Identified for Shoulder Pain 2
(Date:11/25/2009)...5/PRNewswire/--Reportlinker.comannouncesthatanewma... IntranasalDrugDelivery-USMarketTrends&Analys...l-Drug-Delivery---US-Market-Trends--Analysis.html ...nganexpansionoftherapeuticapplicationsfromthedeliv...yofsystemictherapeuticdrugs.Thefutureofthetechnolo...
(Date:11/24/2009)...Nov.24/PRNewswire-Asia/--ChindexInternational,Inc....ricanproviderofWestern,healthcareproductsandservic...theCompanywillattendthe21stAnnualPiperJaffray,"Unp...09,atthe,NewYorkPalaceHotel. , Managementiscu...ember1,2009,andholdone-on-onemeetingsthroughoutthe...
(Date:11/24/2009)....,Nov.24/PRNewswire-FirstCall/--Vermillion,Inc.(VR...anofReorganizationandDisclosureStatementtoday,Nove...heDistrictofDelaware.Ahearingtoconsiderapprovaloft...er8,2009,withthehearingontheconfirmationofthePlans...Companytopayallclaimsinfull.ThePlanisexpected,ifap...
Breaking Medicine Technology:Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5Chindex International to Present at Piper Jaffray Health Care Conference 2Vermillion Files Plan of Reorganization 2Vermillion Files Plan of Reorganization 3Music is the engine of new U M lab on a chip device 9321 1Music is the engine of new U M lab on a chip device 9321 2Stunting plants skyward reach could lead to improved yields 9318 1Stunting plants skyward reach could lead to improved yields 9318 2Public Health Experts Discuss Infectious Diseases Threats at News Conference 52432 1Public Health Experts Discuss Infectious Diseases Threats at News Conference 52432 2Public Health Experts Discuss Infectious Diseases Threats at News Conference 52432 3Public Health Experts Discuss Infectious Diseases Threats at News Conference 52432 4
...ns for treating returning vets and others exposed ... Schepens Eye Research Institute have shown for th...ause both eyes to lose a special protective abilit...ects the eye without the inflammation of the body,... delicate eye tissue. This finding, published in t...
...ExonHit Therapeutics,(Alternext: ALEHT) is pleased... lead compound in Alzheimer,s disease, is progress...l assessing EHT 0202 in patients with,Alzheimer,s ...tion of patient enrolment for the Phase IIa,repres...EHT 0202, and,provides a clear timeline for the re...
Other Medicine Technology:Laser Burn Injuries in One Eye Can Disrupt Protective Immune Privilege in Both Eyes, Study Finds 2ExonHit Therapeutics Reports Advancements in the Clinical Development of EHT 0202, its Phase II Drug for Alzheimer's Disease 2ExonHit Therapeutics Reports Advancements in the Clinical Development of EHT 0202, its Phase II Drug for Alzheimer's Disease 3ExonHit Therapeutics Reports Advancements in the Clinical Development of EHT 0202, its Phase II Drug for Alzheimer's Disease 4
Naked Gold 20 nm
Naked Gold 20 nm - 50 OD
CranioFix2 Titanium Clamp System
...ate, reliable, portable, and easy-to-use pachymete... a dual-rechargeable battery system that makes cha...lution, color, touch screen controls make operatin...ent software simplifies calculating adjustments to...
Medicine Products: